Changes in cytokine levels and NK cell activation associated with influenza

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Jost, Stephanie ^a   Quillay, Heloise ^a   Reardon, Jeff ^a   Peterson, Eric ^a   Simmons, Rachel P ^a   Parry, Blair A ^a   Bryant, Nancy N P ^a   Binder, William D ^a   Altfeld, Marcus ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NATURAL KILLER CELL RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

2009 H1N1 INFLUENZA; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL SUBPOPULATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MALE; NATURAL KILLER CELL; PHENOTYPE; PROTEIN BLOOD LEVEL; VIRUS STRAIN; BIOSYNTHESIS; CYTOLOGY; FLOW CYTOMETRY; INFLAMMATION; INFLUENZA; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MONONUCLEAR CELL; ORTHOMYXOVIRUS; VIROLOGY;

MURINAE; ORTHOMYXOVIRIDAE;

ADULT; ANTIGENS, CD; ANTIGENS, CD56; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; PHENOTYPE;

EID: 80053103401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025060     Document Type: Article

References (61)

1. World Health Organization website Seasonal influenza fact sheet last updated April 2009. Available: http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed 2011 August 30.
2. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, et al. (2004) Influenza-associated hospitalizations in the United States. JAMA: the journal of the American Medical Association 292: 1333-1340.
3. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
4. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, et al. (2009) Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respi Viruses 3: 37-49.
5. Couch RB, (2008) Seasonal inactivated influenza virus vaccines. Vaccine 26 (Suppl 4): D5-9.
6. Centers for Disease Control and Prevention website MMWR Morbidity and mortality weekly report. Update: novel influenza A (H1N1) virus infections- worldwide, May 6, 2009. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5817a1.htm. Accessed 2011 August 30.
7. Scalera NM, Mossad SB, (2009) The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgraduate medicine 121: 43-47.
8. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, et al. (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nature biotechnology 27: 797-799.
9. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117.
10. Thomas PG, Keating R, Hulse-Post DJ, Doherty PC, (2006) Cell-mediated protection in influenza infection. Emerg Infect Dis 12: 48-54.
11. Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, et al. (2003) Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 171: 915-923.
12. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, et al. (2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103: 664-672.
13. Denney L, Aitken C, Li CK, Wilson-Davies E, Kok WL, et al. (2010) Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PloS one 5: e10675.
14. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, et al. (2007) NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 178: 2688-2698.
15. Du N, Zhou J, Lin X, Zhang Y, Yang X, et al. (2010) Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 84: 7822-7831.
16. Ennis FA, Meager A, Beare AS, Qi YH, Riley D, et al. (1981) Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet 2: 891-893.
17. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
18. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, et al. (2009) The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 87: 579-589.
19. Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, et al. (2008) H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. Journal of virology 82: 2028-2032.
20. Kos FJ, Engleman EG, (1996) Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 173: 1-6.
21. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, et al. (2004) Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85: 423-428.
22. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
23. Owen RE, Yamada E, Thompson CI, Phillipson LJ, Thompson C, et al. (2007) Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol 81: 11170-11178.
24. Siren J, Sareneva T, Pirhonen J, Strengell M, Veckman V, et al. (2004) Cytokine and contact-dependent activation of natural killer cells by influenza A or Sendai virus-infected macrophages. J Gen Virol 85: 2357-2364.
25. Stein-Streilein J, Bennett M, Mann D, Kumar V, (1983) Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol 131: 2699-2704.
26. Stein-Streilein J, Guffee J, (1986) In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol 136: 1435-1441.
27. Stein-Streilein J, Guffee J, Fan W, (1988) Locally and systemically derived natural killer cells participate in defense against intranasally inoculated influenza virus. Reg Immunol 1: 100-105.
28. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA, (2004) NK cell and DC interactions. Trends Immunol 25: 47-52.
29. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, et al. (2007) The trafficking of natural killer cells. Immunol Rev 220: 169-182.
30. Reynolds CW, Timonen T, Herberman RB, (1981) Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 127: 282-287.
31. Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM, (2008) Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 129: 223-230.
32. Dong L, Mori I, Hossain MJ, Kimura Y, (2000) The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 182: 391-396.
33. Alter G, Teigen N, Ahern R, Streeck H, Meier A, et al. (2007) Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 195: 1452-1460.
34. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, et al. (2010) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med.
35. Kuijpers TW, Baars PA, Dantin C, van den Burg M, van Lier RA, et al. (2008) Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
36. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, et al. (1990) Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. The Journal of experimental medicine 171: 1509-1526.
37. Cooper MA, Fehniger TA, Caligiuri MA, (2001) The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640.
38. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, et al. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97: 3146-3151.
39. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, et al. (2003) Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proceedings of the National Academy of Sciences of the United States of America 100: 15011-15016.
40. Biron CA, (2010) Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation. PLoS Pathog 6: e1000816.
41. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E, (2005) Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106: 2252-2258.
42. Sanchez-Cordon PJ, Nunez A, Salguero FJ, Pedrera M, Fernandez de Marco M, et al. (2005) Lymphocyte apoptosis and thrombocytopenia in spleen during classical swine fever: role of macrophages and cytokines. Veterinary pathology 42: 477-488.
43. Chen RF, Chang JC, Yeh WT, Lee CH, Liu JW, et al. (2006) Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS). Microbes and infection/ Institut Pasteur 8: 122-127.
44. Mao H, Tu W, Qin G, Law HK, Sia SF, et al. (2009) Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 83: 9215-9222.
45. Long BR, Michaelsson J, Loo CP, Ballan WM, Vu BA, et al. (2008) Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol 15: 120-130.
46. Bjorkstrom NK, Ljunggren HG, Sandberg JK, (2010) CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends in immunology 31: 401-406.
47. Jost S, Reardon J, Peterson E, Poole D, Bosch R, et al. (2010) Expansion of 2B4+ NK cells and decrease in NKp46+ NK cells in response to influenza. Immunology.
48. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature medicine 12: 1203-1207.
49. Lipatov AS, Andreansky S, Webby RJ, Hulse DJ, Rehg JE, et al. (2005) Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. The Journal of general virology 86: 1121-1130.
50. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, et al. (2007) Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. Journal of virology 81: 2736-2744.
51. Heltzer ML, Coffin SE, Maurer K, Bagashev A, Zhang Z, et al. (2009) Immune dysregulation in severe influenza. Journal of leukocyte biology 85: 1036-1043.
52. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, et al. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362: 263-270.
53. Roberts L, Passmore JA, Williamson C, Little F, Bebell LM, et al. (2010) Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 24: 819-831.
54. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, et al. (2009) Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. Journal of virology 83: 3719-3733.
55. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG, (2001) Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. Journal of medical virology 64: 262-268.
56. He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, et al. (2004) T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J Clin Invest 114: 1812-1819.
57. Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ, (1997) The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain research 776: 96-104.
58. McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, et al. (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. Journal of immunology 182: 7353-7363.
59. Sun J, Madan R, Karp CL, Braciale TJ, (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature medicine 15: 277-284.
60. Sun K, Torres L, Metzger DW, (2010) A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. Journal of virology 84: 5007-5014.
61. Alter G, Malenfant JM, Altfeld M, (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.